Asston Pharmaceuticals IPO
GMP, Subscription, Price, Dates & Financial Details
Asston Pharmaceuticals Limited is an Indian pharmaceutical and nutraceutical manufacturer and exporter operating under the brand name “Asston”. The company primarily caters to domestic and African markets, focusing on affordable, high-quality formulations.Core Operations:Product Categories:…
Open Date
Wed, 09 Jul 2025
Close Date
Fri, 11 Jul 2025
Price Band
₹ 115 – 123
Lot Size
1000
Issue Size
₹ 27.56 Cr
Minimum Investment
₹ 246,000 (2000 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Asston Pharmaceuticals IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹27.56 Crore, comprising a fresh issue of 22.41 Lakh equity shares aggregating to ₹27.56 Crore.
The Asston Pharmaceuticals IPO remained open for subscription from July 09, 2025, to July 11, 2025. The basis of allotment was finalized on July 14, 2025, and the company's shares were listed on BSE SME Platform on July 16, 2025.
The company had fixed the price band at ₹115 to ₹123 per share, with a lot size of 1000 shares. Retail investors were required to make a minimum investment of ₹246,000 (based on the upper price band) to apply for one lot.
Maashitla Securities Pvt. Limited served as the registrar to the issue. Sobhagya Capital Options Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Asston Pharmaceuticals Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Asston Pharmaceuticals IPO Timeline (Tentative)
- IPO Open Date
- Wed, 09 Jul 25
- IPO Close Date
- Fri, 11 Jul 25
- Basis of Allotment
- Mon, 14 Jul 25
- Initiation of Refunds
- Tue, 15 Jul 25
- Credit of Shares to Demat
- Tue, 15 Jul 25
- Listing Date
- Wed, 16 Jul 25 — NSE & BSE
Open Date
09 July 2025
Close Date
11 July 2025
Basis Of Allotment
14 July 2025
Listing Date
16 July 2025
IPO Subscription
Check Live Subscription →The Asston Pharmaceuticals IPO has received bids for 27,86,91,000 shares against 21,28,000 shares offered, resulting in an overall subscription of 130.96x. the NII category is subscribed 353.5x, Retail Investors 172.14x, and QIBs 34.39x.
QIB
34.39x
NII
353.5x
RII
172.14x
Total
130.96x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 7,46,000 shares, representing 35.06% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 10,60,000 shares (49.81%), while Non-Institutional Investors (NIIs) receive 3,22,000 shares (15.13%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,060,000 | 49.81% |
| Non-Institutional | 322,000 | 15.13% |
| Retail Investors | 746,000 | 35.06% |
| Total | 2,128,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Revenue | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| Net Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserve & Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowings | 7.83 | 7.26 | 6.82 | 5.25 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Asston Pharmaceuticals Limited KPI Information
| Particular | KPI as of Mon, Mar 31, 2025. |
|---|---|
| ROE % | 50.56 |
| ROCE % | 51.25 |
| Debt / Equity | 0.68 |
| RoNW % | 40.36 |
| Pat Margin % | 17.27 |
Peers Comparison
No Peer Comparision Available
About Asston Pharmaceuticals Limited
Asston Pharmaceuticals Limited is an Indian pharmaceutical and nutraceutical manufacturer and exporter operating under the brand name “Asston”. The company primarily caters to domestic and African markets, focusing on affordable, high-quality formulations.
Core Operations:
- Product Categories: Tablets, Capsules, Syrups, Oral Powders (Sachets, Dry Syrups), External Preparations (Ointments, Creams, Gels, Lotions), Injectables (LVP & SVP).
- Business Model:
- Direct manufacturing and marketing.
- Contract manufacturing and loan licensing for corporate clients.
- Production Facility: Located in Ambernath, Maharashtra, with separate floors for:
- Pharmaceuticals (FDA-governed)
- Nutraceuticals (FSSAI-governed)
Manufacturing Capabilities:
- Tablets: Capacity of 8–9 crore tablets/month; average production 5–6 crore/month.
- Syrups (Nutraceuticals): ~37.5 kiloliters/month.
- Sachets: 30–40 lakh/month (depending on weight).
- Facility includes QA/QC labs, warehouse, and is FDA-certified (Central and State) and NQA-accredited.
Quality and Regulatory Compliance:
- WHO-GMP certified contract manufacturers.
- Own regulatory department and tie-ups with NABL-accredited labs.
- Complies with Quality Management System (QMS) standards.
- Operations fall under green and orange environmental zones.
- Over 150 registered trademarks for formulations.
Products and Markets:
- Broad range includes generic medicines, pediatric drugs, eye drops, NTTB (New to the Basket) treatments.
- Distributed across more than 10 countries, including South Africa and West Africa.
- Focus on price-sensitive markets with low-cost, quality formulations.
Growth and Development:
- Founded: April 16, 2019, as a private limited company.
- Acquired Ferron Lifecare’s nutraceutical plant in Ambernath in April 2024.
- Converted to a public limited company on August 29, 2024.
- FDA approval for pharmaceutical manufacturing received on December 2, 2024.
- Leadership Team: Dr. Ashish Sakalkar, Mrs. Saili More, and Mr. Sachin Badakh.
- Team Size: 50+ employees and expanding.
Strategic Initiatives:
- 5-year contracts with WHO-GMP-certified manufacturers for various formulations.
- Ongoing expansion with a new loan license deal in Gujarat for ointment production.
- In-house regulatory team supports dossier preparation and global compliance for exports.
Asston Pharmaceuticals IPO Promoters
- Dr. Ashish Narayan Sakalkar
- Saili Jayaram More
- Sachin Chandrakant Badakh
Promoters Holding
Holding Pre Issue
68.76%
Holding Post Issue
50.66%
Asston Pharmaceuticals IPO Objective
The Company Asston Pharmaceuticals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
- Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
- Funding the incremental working capital requirements of the Company
- Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company
- General Corporate Purposes
Asston Pharmaceuticals Limited Address / Contact Details
Asston Pharmaceuticals Limited
4th Floor, Office No. A-431 Balaji Bhavan,
Plot No 42A Sector-11 CBD Belapur,
Navi Mumbai, Thane
Navi Mumbai, Maharashtra, 400614
Phone: +91 22 49731411
Email: info@asstonpharmaceuticals.com
Website: http://www.asstonpharmaceuticals.com/
IPO Snapshot
Asston Pharmaceuticals IPO Lot Size
The Asston Pharmaceuticals IPO has a lot size of 1,000 shares. Retail investors require a minimum investment of ₹2,46,000 by applying for 2 lot (2,000 shares). The maximum application allowed for the retail category is 2 lots (2,000 shares), requiring an investment of ₹2,46,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 246,000.00 |
| Retail (Max) | 2 | 2,000 | 246,000.00 |
| S-HNI (Min) | 3 | 3,000 | 369,000.00 |
| S-HNI (Max) | 8 | 8,000 | 984,000.00 |
| B-HNI (Min) | 9 | 9,000 | 1,107,000.00 |
Issue Reservation
- QIB — 49.81%
- NII — 15.13%
- RII — 35.06%
Book Running Lead Managers
- Sobhagya Capital Options Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Asston Pharmaceuticals IPO?
Asston Pharmaceuticals IPO is a Book-building IPO with a total issue size of ₹27.56 crore. The Asston Pharmaceuticals IPO price band is ₹115 to 123 per share. The Asston Pharmaceuticals IPO subscription opens on Wed, Jul 9, 2025, and closes on Fri, Jul 11, 2025. The Asston Pharmaceuticals IPO will be listed on the BSE. Maashitla Securities Pvt. Limited is the registrar for the Asston Pharmaceuticals IPO.
When will the Asston Pharmaceuticals IPO open for subscription?
The Asston Pharmaceuticals IPO opens on Wed, Jul 9, 2025 and closes on Fri, Jul 11, 2025
What is Asston Pharmaceuticals IPO Price Band?
Asston Pharmaceuticals IPO Price Band is ₹115 to 123 per share.
What is Asston Pharmaceuticals IPO Lot Size?
Asston Pharmaceuticals IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹246000 based on the upper price band
What is the minimum investment for Asston Pharmaceuticals IPO?
The minimum investment for Asston Pharmaceuticals IPO is ₹246000, based on one lot of 1000 shares at the upper price band of ₹123 per share.
How to apply for Asston Pharmaceuticals IPO?
Investors can apply for the Asston Pharmaceuticals IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jul 11, 2025. The application amount remains blocked until the Asston Pharmaceuticals IPO allotment is finalized.
What is Asston Pharmaceuticals IPO Issue Size?
Asston Pharmaceuticals IPO issue size is ₹27.56 crores.
What is the Asston Pharmaceuticals IPO Allotment Date?
Asston Pharmaceuticals IPO allotment date is Mon, Jul 14, 2025.
Who is the Asston Pharmaceuticals IPO Registrar?
The registrar for Asston Pharmaceuticals IPO is Maashitla Securities Pvt. Limited. Investors can go to Maashitla Securities Pvt. Limited website to check Asston Pharmaceuticals IPO allotment status, refund processing, and other IPO-related information.
What is the Asston Pharmaceuticals IPO GMP?
The Asston Pharmaceuticals IPO GMP (Grey Market Premium) is ₹26 as of Wed, Jul 16, 2025. Based on the upper price band of ₹123 per share, the estimated Asston Pharmaceuticals IPO listing price is ₹149, indicating a potential listing gain of approximately 21.14% over the issue price.
Who is the Asston Pharmaceuticals IPO Lead Manager?
The book-running lead managers (BRLMs) for the Asston Pharmaceuticals IPO are Sobhagya Capital Options Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Asston Pharmaceuticals IPO Red Herring Prospectus (RHP).